Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT.

Abstract

PURPOSE:

Prostate-specific membrane antigen (PSMA) is expressed ubiquitously on the membrane of most prostate tumors and its metastasis. While PET/CT using 11C-choline was considered as the gold standard in the staging of prostate cancer, PET with radiolabelled PSMA ligands was introduced into the clinic in recent years. Our aim was to compare the PSMA ligand 68Ga-PSMA-11 with 11C-choline in patients with primary and recurrent prostate cancer.

METHODS:

123 patients underwent a whole-body PET/CT examination using 68Ga-PSMA-11 and 11C-choline. Suspicious lesions were evaluated visually and semiquantitatively (SUVavg). Out of these, 103 suffered from a confirmed biochemical relapse after prostatectomy and/or radiotherapy (mean PSA level of 4.5 ng/ml), while 20 patients underwent primary staging.

RESULTS:

In 67 patients with biochemical relapse, we detected 458 lymph nodes suspicious for metastasis. PET using 68Ga-PSMA-11 showed a significantly higher uptake and detection rate than 11C-choline PET. Also 68Ga-PSMA-11 PET identified significantly more patients with suspicious lymph nodes as well as affected lymph nodes regions especially at low PSA levels. Bone lesions suspicious for prostate cancer metastasis were revealed in 36 patients' biochemical relapse. Significantly more bone lesions were detected by 68Ga-PSMA-11, but only 3 patients had only PSMA-positive bone lesions. Nevertheless, we detected also 29 suspicious lymph nodes and 8 bone lesions, which were only positive as per 11C-choline PET. These findings led to crucial differences in the TNM classification and the identification of oligometastatic patients. In the patients who underwent initial staging, all primary tumors showed uptake of both tracers. Although significantly more suspicious lymph nodes and bone lesions were identified, only 2 patients presented with bone lesions only detected by 68Ga-PSMA-11 PET.

CONCLUSION:

Thus, PET using 68Ga-PSMA-11 showed a higher detection rate than 11C-choline PET for lymph nodes as well as bone lesions. However, we found lymph nodes and bone lesions which were not concordant applying both tracers.

• Authors: Johannes Schwenck, Hansjoerg Rempp, Gerald Reischl, Stephan Kruck, Arnulf Stenzl, Konstantin Nikolaou, Christina Pfannenberg, Christian la Fougère
• Journal: European journal of nuclear medicine and molecular imaging (Eur J Nucl Med Mol Imaging) Vol. 44 Issue 1 Pg. 92-101 (Jan 2017) ISSN: 1619-7089 [Electronic] Germany
• PMID: 27557844 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Gallium Isotopes
• Gallium Radioisotopes
• Oligopeptides
• Organometallic Compounds
• Radiopharmaceuticals
• gallium 68 PSMA-11
• methyl carbon-11 choline
• Edetic Acid
• Choline

Topics

• Aged
• Aged, 80 and over
• Bone Neoplasms (diagnostic imaging, secondary)
• Choline (analogs & derivatives)
• Edetic Acid (analogs & derivatives)
• Gallium Isotopes
• Gallium Radioisotopes
• Humans
• Lymphatic Metastasis
• Male
• Middle Aged
• Oligopeptides
• Organometallic Compounds
• Positron Emission Tomography Computed Tomography (methods)
• Prostatic Neoplasms (diagnostic imaging)
• Radiopharmaceuticals
• Reproducibility of Results
• Sensitivity and Specificity
• Sentinel Lymph Node (diagnostic imaging)
• Whole Body Imaging